Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$36.22
0.41.12%
At close: -
$36.22
00.00%
After Hours: 4:48 PM EDT
Comments
Loading...
Supernus Pharmaceuticals (SUPN) Forecast
NewsEarningsSupernus Pharmaceuticals (SUPN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Quotes, Forecast and News Summary
Supernus Pharmaceuticals Stock (NASDAQ: SUPN) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Supernus Pharmaceuticals (SUPN) stock?
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Who are Supernus Pharmaceuticals (SUPN) competitors?
Other companies in Supernus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
What is the forecast, or price target, for Supernus Pharmaceuticals (SUPN) stock?
Supernus Pharmaceuticals has a consensus price target of $36.00.
What is the current price for Supernus Pharmaceuticals (SUPN)?
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $36.22 last updated November 22, 2024 at 4:48 PM EST.
Does Supernus Pharmaceuticals (SUPN) pay a dividend?
There are no upcoming dividends for Supernus Pharmaceuticals.
When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?
Supernus Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is Supernus Pharmaceuticals (SUPN) going to split?
There is no upcoming split for Supernus Pharmaceuticals.
What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.